Exhibit 99.1

FOR IMMEDIATE RELEASE

CONTACT:	Abdo H. Khoury
	Chief Financial and Portfolio Officer
	(949) 718-4400

NHP REPORTS THIRD QUARTER 2007 REVENUE AND

FFO GROWTH AND ENHANCED DISCLOSURE INFORMATION

(NEWPORT BEACH, California, November 6, 2007)… Nationwide Health Properties, Inc. (NYSE:NHP) today announced its third quarter and nine months 2007 operating results and investment activity.

“The third quarter was a good one for NHP with revenues up 28% and normalized FFO per share up 8%,” commented Douglas M. Pasquale, NHP’s President and Chief Executive Officer. “During the quarter we closed $150 million of accretive investments, bringing our total for 2007 to $685 million. With over $300 million of investments expected to close in the fourth quarter, 2007 should make for another $1 billion investment year. We also greatly enhanced our supplemental disclosure package that is distributed on request and is available on our website,” Mr. Pasquale added.

1

2007 THIRD QUARTER RESULTS

The following table presents selected financial results for the third quarter of 2007 as compared to the third quarter of 2006:

SELECTED FINANCIAL RESULTS

($ in thousands, except per share amounts)

Three Months Ended September 30,

Item	2007		2006		Change
Revenues	$	87,030	$	67,781	$	19,249	28.4	%
Income from Continuing Operations	$	57,752	$	17,487	$	40,265	230.3	%
Net Income	$	57,742	$	31,719	$	26,023	82.0	%
Diluted Income from Continuing Operations Available to Common Stockholders Per Share	$	0.58	$	0.17	$	0.41	241.2	%
Diluted Income from Continuing Operations Excluding Gains on Sale Per Share	$	0.28	$	0.17	$	0.11	64.7	%
Diluted Income Available to Common Stockholders Per Share	$	0.58	$	0.34	$	0.24	70.6	%
Diluted FFO	$	52,926	$	42,627	$	10,299	24.2	%
Diluted FFO Per Share	$	0.55	$	0.49	$	0.06	12.2	%
Normalized Diluted FFO	$	50,961	$	42,627	$	8,334	19.6	%
Normalized Diluted FFO Per Share	$	0.53	$	0.49	$	0.04	8.2	%
Nine Months Ended September 30,
Revenues	$	243,735	$	180,101	$	63,634	35.3	%
Income from Continuing Operations	$	105,640	$	48,008	$	57,632	120.0	%
Net Income	$	171,222	$	82,821	$	88,401	106.7	%
Diluted Income from Continuing Operations Available to Common Stockholders Per Share	$	1.04	$	0.49	$	0.55	112.2	%
Diluted Income from Continuing Operations Excluding Gains on Sale Per Share	$	0.71	$	0.49	$	0.22	44.9	%
Diluted Income Available to Common Stockholders Per Share	$	1.77	$	0.95	$	0.82	86.3	%
Diluted FFO	$	148,212	$	115,997	$	32,215	27.8	%
Diluted FFO Per Share	$	1.56	$	1.45	$	0.11	7.6	%
Normalized Diluted FFO	$	146,247	$	116,080	$	30,167	26.0	%
Normalized Diluted FFO Per Share	$	1.54	$	1.45	$	0.09	6.2	%

Funds From Operations (FFO)

FFO is a non-GAAP measure that NHP believes is important to an understanding of its operations. A reconciliation between net income, the most directly comparable GAAP financial measure, and FFO is included in the accompanying financial data. We believe FFO is an important supplemental measure of operating performance because it excludes the effects of depreciation and gains (losses) from sales of facilities (both of which are based on historical costs and which may be of limited relevance in evaluating current performance).

2

The normalized FFO amounts above exclude approximately $2 million of previously reserved rent, interest and late charges (representing the entire amount due from the tenant) recognized when paid during the third quarter of 2007 on a portfolio of four assets, three of which were transferred to a new operator and included in a master lease. These results include gains on the sale of certain assets shown in the accompanying income statement that caused the income from continuing operations and net income results in 2007 to be significantly higher than in 2006. Income from continuing operations does not include the gains on sale or the operations of facilities sold that qualified as discontinued operations for any period presented in the accompanying income statement, however it does include the gains on sale and historical operations of facilities we sold to our unconsolidated joint venture.

NEW INVESTMENTS

The following tables summarize our third quarter and year-to-date investment activity:

THIRD QUARTER 2007 CLOSED INVESTMENTS

Type	Amount (millions)		Unit Price (thousands)		Cap Rate		Initial Yield		CPI Ups		DARM Cover
Senior Housing	$	36	$	94	8.7	%	8.6	%	2.8	%	1.3	x
Long-Term Care	$	58	$	57	16.7	%	8.7	%	2.2	%	2.4	x
Medical Office	$	56	$	179/sf	7.1	%	7.1	%
Total	$	150
2007 CLOSED INVESTMENTS
Type	Amount (millions)		Unit Price (thousands)		Cap Rate		Initial Yield		CPI Ups		DARM Cover
Senior Housing	$	236	$	95	8.7	%	8.3	%	2.8	%	1.3	x
CCRC	$	39	$	74	11.1	%	8.8	%	2.5	%	1.6	x
Long-Term Care	$	284	$	81	11.5	%	8.5	%	2.2	%	1.9	x
Medical Office	$	79	$	174/sf	7.2	%	7.2	%
Subtotal	$	638
Loans	$	47					11.0	%
Total	$	685

3

Included in these numbers are third party investments financed through our unconsolidated joint venture which are broken out in the supplemental information package (which exclude the twelve facilities acquired by the joint venture from us for $143 million during 2007). Approximately 75% of the acquired loans mature in 2007 and 2008.

2007 FINANCING TRANSACTIONS

During the first nine months of 2007, we issued approximately 5.3 million shares through our controlled equity offering program at an average price of $31.44 per share resulting in net proceeds of approximately $164 million.

On October 1, 2007, we redeemed all 900,485 shares of our Series A Cumulative Preferred Step-Up REIT Securities at their $100 per share redemption value for a total of $90,048,500. The final dividend on these shares was paid concurrently.

On October 19, 2007, we issued $300 million of 6.25% senior unsecured notes maturing on February 1, 2013, resulting in net proceeds of approximately $297 million after deducting expected underwriting discounts and other expenses. During the months of August and September, we hedged the treasury rate on $250 million of the offering resulting in a cash payment to us of $1.6 million that will reduce our interest expense over the life of the notes.

2007 GUIDANCE

We are increasing our full-year 2007 guidance range for FFO before impairments, acquisitions and capital transactions and are changing the range from between $2.03 and $2.07 per share to between $2.07 and $2.09 per share, inclusive of the $0.02 per share of non-recurring FFO from the collection of previously reserved rent, interest and late fees

4

noted above. Accordingly, our normalized FFO guidance range will be from between $2.05 to $2.07 per share. A reconciliation between net income per share, FFO per share and normalized FFO per share for the guidance range is included in the accompanying financial data.

Although we expect to continue making accretive acquisitions in 2007 and have over $300 million of investments in the fourth quarter closing queue, this guidance incorporates no results from acquisitions other than those included in the closed investments tables above, nor does it incorporate the impact of any future impairments that might arise. Our guidance does include the effects of the Series A Preferred Stock redemption and the $300 million senior unsecured notes issuance, discussed above, however it excludes any other future capital transactions. This guidance assumes asset sales, mortgage loan receivable prepayments and other expected dispositions during 2007 as described in the supplemental information package available on our website.

CONFERENCE CALL INFORMATION

The Company has scheduled a conference call and webcast on Wednesday, November 7, 2007 at 8:30 a.m. Pacific time in order to present the Company’s performance and operating results for the quarter ended September 30, 2007. The conference call is accessible by dialing (877) 356-5705 and referencing conference ID number 20484508 or by logging on to our website at www.nhp-reit.com. The earnings release and any additional financial information that may be discussed on the conference call will also be available at the same location on our website. A digitized replay of the conference call will be available from 10:00 a.m. Pacific time that day until 9:00 p.m.

5

Pacific time on Thursday, November 22, 2007. Callers can access the replay by dialing (800) 642-1687 or (706) 645-9291 and entering conference ID number 20484508. Webcast replays will also be available on our website for at least 12 months following the conference call. The Company’s supplemental information package for the third quarter and nine months ended September 30, 2007 will be available on our website, free of charge, at www.nhp-reit.com by selecting financial information followed by analyst information and will also be included in our 8-K filed November 6, 2007 with the SEC containing this release.

Nationwide Health Properties, Inc. is a real estate investment trust that invests in senior housing facilities, long-term care facilities and medical office buildings. The Company has investments in 547 facilities in 43 states. For more information on Nationwide Health Properties, Inc., visit our website at www.nhp-reit.com.

###

Certain information contained in this news release includes forward-looking statements. Forward-looking statements include statements regarding our expectations, beliefs, intentions, plans, objectives, goals, strategies, future events or performance and underlying assumptions and other statements which are not statements of historical facts. These statements may be identified, without limitation, by the use of forward-looking terminology such as “may,” “will,” “anticipates,” “expects,” “believes,” “intends,” “should” or comparable terms or the negative thereof. All forward-looking statements included in this news release are based on information available to us on the date hereof. These statements speak only as of the date hereof, and we assume no obligation to update such forward-looking statements for any reason or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. These statements involve risks and uncertainties that could cause actual results to differ materially from those described in the statements. These risks and uncertainties include (without limitation) the following: deterioration in the operating results or financial condition, including bankruptcies, of our tenants; non-payment or late payment of rent by our tenants; our reliance on two operators for a significant percentage of our revenues; occupancy levels at certain facilities; our level of indebtedness; changes in the ratings of our debt securities; access to the capital markets and the cost of capital; government regulations, including changes in the reimbursement levels under the Medicare and Medicaid programs; the general distress of the healthcare industry; increasing competition in our business sector; the

6

effect of economic and market conditions and changes in interest rates; the amount and yield of any additional investments; our ability to meet acquisition goals; the ability of our operators to repay deferred rent or loans in future periods; the ability of our operators to obtain and maintain adequate liability and other insurance; our ability to attract new operators for certain facilities; our ability to sell certain facilities for their book value; our ability to retain key personnel; potential liability under environmental laws; the possibility that we could be required to repurchase some of our medium-term notes; the rights and influence of holders of our outstanding preferred stock; changes in or inadvertent violations of tax laws and regulations and other factors that can affect real estate investment trusts and our status as a real estate investment trust; and the risk factors described in our most recent annual report on Form 10-K and any subsequent quarterly reports on Form 10-Q filed with the SEC.

7

Consolidated Balance Sheets

In thousands

	September 30, 2007			December 31, 2006
Assets
Real estate related investments:
Land	$	296,011		$	267,303
Buildings and improvements		2,822,405			2,581,484
		3,118,416			2,848,787
Less accumulated depreciation		(416,425	)		(372,201	)
Net real estate		2,701,991			2,476,586
Mortgage loans receivable, net		130,558			106,929
Investment in unconsolidated joint venture		34,278			—
Net real estate related investments		2,866,827			2,583,515
Cash and cash equivalents		14,953			14,695
Receivables, net		4,092			7,787
Assets held for sale		—			9,484
Other assets		103,778			89,333
Total assets	$	2,989,650		$	2,704,814
Liabilities and Stockholders’ Equity
Credit facility	$	216,000		$	139,000
Senior notes due 2008 - 2038		866,500			887,500
Notes and bonds payable		329,636			355,411
Accounts payable and accrued liabilities		99,620			77,829
Total liabilities		1,511,756			1,459,740
Minority interest		2,201			1,265
Stockholders’ equity:
Series A preferred stock		90,049			90,049
Series B convertible preferred stock		106,445			106,450
Common stock		9,209			8,624
Capital in excess of par value		1,481,510			1,298,703
Cumulative net income		1,235,515			1,064,293
Accumulated other comprehensive income		1,183			1,231
Cumulative dividends		(1,448,218	)		(1,325,541	)
Total stockholders’ equity		1,475,693			1,243,809
Total liabilities and stockholders’ equity	$	2,989,650		$	2,704,814

Reconciliation of Net Income to Funds From Operations (FFO)

In thousands, except per share data

	Three Months Ended September 30,						Nine Months Ended September 30,
	2007			2006			2007			2006
Net income to FFO
Net income	$	57,742		$	31,719		$	171,222		$	82,821
Preferred stock dividends		(3,791	)		(3,791	)		(11,372	)		(11,372	)
Real estate related depreciation and amortization		25,799			21,319			72,375			55,869
Depreciation in income from unconsolidated joint venture		503			—			1,034			—
Gains on sale of facilities		(29,389	)		(8,682	)		(91,234	)		(17,508	)
FFO available to common stockholders		50,864			40,565			142,025			109,810
Series B preferred dividend add-back		2,062			2,062			6,187			6,187
Diluted FFO		52,926			42,627			148,212			115,997
Impairments		—			—			—			83
Non-recurring settlement of delinquent tenant obligations		(1,965	)		—			(1,965	)		—
Recurring diluted FFO	$	50,961		$	42,627		$	146,247		$	116,080
Weighted average shares outstanding for FFO
Diluted weighted average shares outstanding		96,255			82,003			90,158			75,288
Series B preferred stock add-back		—			4,689			4,704			4,686
Fully diluted weighted average shares outstanding		96,255			86,692			94,862			79,974
Diluted per share amounts:
FFO	$	0.55		$	0.49		$	1.56		$	1.45
Recurring FFO	$	0.53		$	0.49		$	1.54		$	1.45
Dividends declared per common share	$	0.41		$	0.39		$	1.23		$	1.15
Recurring FFO payout ratio		77	%		80	%		80	%		79	%
Recurring FFO Coverage		1.29			1.26			1.25			1.26

Reconciliation of 2007 Net Income Guidance to 2007 Diluted FFO Guidance

	Low			High
Net income	$	2.36		$	2.38
Less: preferred stock dividends		(0.06	)		(0.06	)
Real estate related depreciation and amortization		1.08			1.08
Less: gains on sale		(1.19	)		(1.19	)
Dilution from convertible preferred stock		(0.12	)		(0.12	)
Diluted FFO guidance		2.07			2.09
Non-recurring settlement of delinquent tenant obligations		(0.02	)		(0.02	)
Normalized diluted FFO guidance	$	2.05		$	2.07

Consolidated Statements of Operations

In thousands, except per share data

	Three Months Ended September 30,						Nine Months Ended September 30,
	2007			2006			2007			2006
Revenues:
Triple net lease rent	$	76,904		$	61,242		$	218,757		$	163,333
Medical office building operating rent		3,560			2,479			9,133			6,902
		80,464			63,721			227,890			170,235
Interest and other income		6,566			4,060			15,845			9,866
		87,030			67,781			243,735			180,101
Expenses:
Interest and amortization of deferred financing costs		25,387			24,890			75,484			65,492
Depreciation and amortization		25,880			19,886			71,337			51,174
General and administrative		6,087			4,165			17,501			11,819
Medical office building operating expenses		1,897			1,513			5,103			3,895
		59,251			50,454			169,425			132,380
Income before minority interest and unconsolidated joint venture		27,779			17,327			74,310			47,721
Minority interest in net loss of consolidated joint ventures		76			160			139			287
Income from unconsolidated joint venture		547			—			1,242			—
Gain on sale of facilities to joint venture		29,350			—			29,949			—
Income from continuing operations		57,752			17,487			105,640			48,008
Discontinued operations
Gain on sale of facilities, net		39			8,682			61,285			17,508
Income (loss) from discontinued operations		(49	)		5,550			4,297			17,305
		(10	)		14,232			65,582			34,813
Net income		57,742			31,719			171,222			82,821
Preferred stock dividends		(3,791	)		(3,791	)		(11,372	)		(11,372	)
Income available to common stockholders	$	53,951		$	27,928		$	159,850		$	71,449
Basic earnings per share (EPS):
Income from continuing operations excluding gains	$	0.27		$	0.17		$	0.72		$	0.49
Gains in income from continuing operations		0.32			—			0.33			—
Income from continuing operations		0.59			0.17			1.05			0.49
Discontinued operations		—			0.17			0.73			0.46
Income available to common stockholders	$	0.59		$	0.34		$	1.78		$	0.95
Diluted EPS:
Income from continuing operations excluding gains	$	0.28		$	0.17		$	0.71		$	0.49
Gains in income from continuing operations		0.30			—			0.33			—
Income from continuing operations		0.58			0.17			1.04			0.49
Discontinued operations		—			0.17			0.73			0.46
Income	$	0.58		$	0.34		$	1.77		$	0.95
Weighted average shares outstanding for EPS:
Basic		91,089			81,679			89,690			74,959
Diluted		96,255			82,003			90,158			75,288
Series B Convertible Preferred Dividends in Diluted EPS	$	2,062		$	—		$	—		$	—